Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renata Ferrarotto

Showing results (81-90 of 213) with videos related to

Pageof 22
Sort By:
Cancer|May 16, 2025
Survival outcomes of pulmonary metastasis-directed local therapy in adenoid cystic carcinomaCamilla O Hoff, Lei Feng, Flavia Bonini, et al.
The Journal of Pathology|April 24, 2025
Comparative transcriptomics of salivary basal cell adenoma and adenocarcinoma sustain linear neoplastic evolution and intertumor heterogeneity: classification and biological implicationsYoshitsugu Mitani, Haneen Al-Maghrabi, Tatiana V Karpinets, et al.
F1000Research|October 5, 2019
Recent advances and emerging therapies in anaplastic thyroid carcinomaMaria E Cabanillas, Mark Zafereo, Michelle D Williams, et al.
Thyroid : Official Journal of the American Thyroid Association|November 23, 2017
Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid CarcinomaPriyanka C Iyer, Ramona Dadu, Renata Ferrarotto, et al.
Cancer|October 21, 2020
Hypomagnesemia and survival in patients with head and neck cancers who received primary concurrent chemoradiationWenli Liu, Aiham Qdaisat, Renata Ferrarotto, et al.
Head & Neck|March 24, 2018
Poly ADP-ribose polymerase-1 as a potential therapeutic target in Merkel cell carcinomaRenata Ferrarotto, Robert Cardnell, Shirley Su, et al.
Head & Neck|May 28, 2020
Changing practice patterns in head and neck oncologic surgery in the early COVID-19 eraKimberley L Kiong, Theresa Guo, Christopher M K L Yao, et al.
Cancers|August 12, 2022
Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional StudyMarta Persson, Mattias K Andersson, Yoshitsugu Mitani, et al.
Oral Oncology|December 23, 2019
Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinomaRoberto Carmagnani Pestana, Melody Becnel, Maria Laura Rubin, et al.
Journal for Immunotherapy of Cancer|March 4, 2022
Spontaneous tumor regression following COVID-19 vaccinationLuana Guimaraes de Sousa, Daniel J McGrail, Kaiyi Li, et al.
Pageof 22

Showing results (81-90 of 213) with videos related to

Sort By:
Pageof 22
Cancer|May 16, 2025
Survival outcomes of pulmonary metastasis-directed local therapy in adenoid cystic carcinomaCamilla O Hoff, Lei Feng, Flavia Bonini, et al.
The Journal of Pathology|April 24, 2025
Comparative transcriptomics of salivary basal cell adenoma and adenocarcinoma sustain linear neoplastic evolution and intertumor heterogeneity: classification and biological implicationsYoshitsugu Mitani, Haneen Al-Maghrabi, Tatiana V Karpinets, et al.
F1000Research|October 5, 2019
Recent advances and emerging therapies in anaplastic thyroid carcinomaMaria E Cabanillas, Mark Zafereo, Michelle D Williams, et al.
Thyroid : Official Journal of the American Thyroid Association|November 23, 2017
Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid CarcinomaPriyanka C Iyer, Ramona Dadu, Renata Ferrarotto, et al.
Cancer|October 21, 2020
Hypomagnesemia and survival in patients with head and neck cancers who received primary concurrent chemoradiationWenli Liu, Aiham Qdaisat, Renata Ferrarotto, et al.
Head & Neck|March 24, 2018
Poly ADP-ribose polymerase-1 as a potential therapeutic target in Merkel cell carcinomaRenata Ferrarotto, Robert Cardnell, Shirley Su, et al.
Head & Neck|May 28, 2020
Changing practice patterns in head and neck oncologic surgery in the early COVID-19 eraKimberley L Kiong, Theresa Guo, Christopher M K L Yao, et al.
Cancers|August 12, 2022
Rearrangements, Expression, and Clinical Significance of MYB and MYBL1 in Adenoid Cystic Carcinoma: A Multi-Institutional StudyMarta Persson, Mattias K Andersson, Yoshitsugu Mitani, et al.
Oral Oncology|December 23, 2019
Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinomaRoberto Carmagnani Pestana, Melody Becnel, Maria Laura Rubin, et al.
Journal for Immunotherapy of Cancer|March 4, 2022
Spontaneous tumor regression following COVID-19 vaccinationLuana Guimaraes de Sousa, Daniel J McGrail, Kaiyi Li, et al.
Pageof 22